Home  ›  France  ›  Maat Pharma

Maat Pharma insider transactions

Healthcare · EPA · France
Net insider signal · last quarter
Neutral
Share price & insider trades · last quarter▲ buy   ▼ sell
€ 8.4€ 1.910 Apr09 Jul

Insiders were net buyers over the last quarter — 0 buys against 0 sells — a net €0 of buying. Most recent filing: 27 Jan 2026.

Net insider flow · last quarter
+€00 buys · 0 sells
Insider profiles
＋●.●% avg 3m · win rate
🔒  Subscribe to access

Transactions

DateInsiderRoleTypeValue
27 Jan 2026Seventure Partners Societe Anonyme A DirectoireAdministrateurSell€155,335
26 Jan 2026Seventure Partners Societe Anonyme A DirectoireAdministrateurSell€351,262
09 Jan 2026Seventure Partners Societe Anonyme A DirectoireAdministrateurSell€75,575
Discover the latest filings, live alerts, top insiders and industry rankings →
08 Jan 2026Seventure Partners Societe Anonyme A DirectoireAdministrateur▼ Sell€31,736
07 Jan 2026Seventure Partners Societe Anonyme A DirectoireAdministrateur▼ Sell€332,095
06 Jan 2026Seventure Partners Societe Anonyme A DirectoireAdministrateur▼ Sell€66,025
14 Jan 2025Seventure Partners Societe Anonyme A DirectoireAdministrateur▼ Sell€22,657
Showing older filings · the 3 most recent are subscriber-only
Visit the website →

Under the EU Market Abuse Regulation (MAR), executives and board members (PDMRs) at French-listed companies must disclose dealings in their company's shares to AMF. Insider Transaction Terminal aggregates these filings daily, filters out the noise and gives you the trades that actually matter.